Company / PP&E per Share
Moderna PP&E per Share History
FY2017-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$5.01
FY2022
5-year range
$3.11 / $5.01
FY2018-FY2022
Trend
+61.0%
vs FY2021
Sector context
#17 of 191
Health Care
What the data says
Among 191 Health Care companies, Moderna is in the top 9% for pp&e per share. Improved from $0.64 to $5.01 over the past 3 years.
Based on SEC 10-K filings.
5.01 in FY2022 with a 5-year CAGR of +18.4%. Top quartile in the Health Care sector.
Improved from $0.64 to $5.01 over the past 3 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +98.8%
- 5-Year CAGR
- +18.4%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 191This company $5.01 Sector average $22.34
▼
-77.6% below sector average
Key checks
Key Insights
- In FY2022, pp&e per share increased 61.0% year-over-year.
- Ranks #17 out of 191 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $5.01 | +61.0% |
| FY2021 | $3.11 | - |
| FY2020 | - | - |
| FY2019 | $0.64 | -80.4% |
| FY2018 | $3.25 | +50.8% |
| FY2017 | $2.16 | - |
| FY2016 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026